{"title":"抗生素处方是MRSA的一个危险因素。","authors":"Mark H Wilcox","doi":"10.12968/hmed.2005.66.3.17693","DOIUrl":null,"url":null,"abstract":"<p><p>There is accumulating evidence to support the role of specific antibiotic classes as risk factors for selecting meticillin-resistant Staphylococcus aureus (MRSA). Crucially, however, controlled studies of antimicrobial prescribing interventions are lacking. The evidence for the association between antimicrobial prescribing and expansion of MRSA is reviewed here.</p>","PeriodicalId":79637,"journal":{"name":"Hospital medicine (London, England : 1998)","volume":"66 3","pages":"180-4"},"PeriodicalIF":0.0000,"publicationDate":"2005-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.12968/hmed.2005.66.3.17693","citationCount":"14","resultStr":"{\"title\":\"Antibiotic prescribing as a risk factor for MRSA.\",\"authors\":\"Mark H Wilcox\",\"doi\":\"10.12968/hmed.2005.66.3.17693\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>There is accumulating evidence to support the role of specific antibiotic classes as risk factors for selecting meticillin-resistant Staphylococcus aureus (MRSA). Crucially, however, controlled studies of antimicrobial prescribing interventions are lacking. The evidence for the association between antimicrobial prescribing and expansion of MRSA is reviewed here.</p>\",\"PeriodicalId\":79637,\"journal\":{\"name\":\"Hospital medicine (London, England : 1998)\",\"volume\":\"66 3\",\"pages\":\"180-4\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2005-03-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.12968/hmed.2005.66.3.17693\",\"citationCount\":\"14\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Hospital medicine (London, England : 1998)\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.12968/hmed.2005.66.3.17693\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Hospital medicine (London, England : 1998)","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.12968/hmed.2005.66.3.17693","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
There is accumulating evidence to support the role of specific antibiotic classes as risk factors for selecting meticillin-resistant Staphylococcus aureus (MRSA). Crucially, however, controlled studies of antimicrobial prescribing interventions are lacking. The evidence for the association between antimicrobial prescribing and expansion of MRSA is reviewed here.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
